Skip to main content
Premium Trial:

Request an Annual Quote

Berkeley Lights Prices Upsized $178.2M IPO

NEW YORK – Berkeley Lights announced Thursday it expects to raise $178.2 million in an upsized initial public offering priced above the expected range.

The maker of instruments for cell engineering said in a statement it will offer 8.1 million shares of common stock at $22 per share. Previously the firm had said it would offer 7.4 million shares at an estimated price of $16 to $18 per share.

Berkeley Lights has granted the underwriters a 30-day option to purchase up to an additional 1,215,000 shares of stock at the IPO price, less the underwriting discounts and commissions. JP Morgan, Morgan Stanley, and Cowen are acting as lead book-running managers for the offering. William Blair is acting as a co-manager.

Based in Emeryville, California, Berkeley Lights offers the Beacon Optofluidic System, a platform for finding cells of interest.

Shares of Berkeley Lights will trade on the Nasdaq under ticker symbol BLI. The offering is expected to close on July 21, subject to customary closing conditions.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.